Published in Hered Cancer Clin Pract on September 07, 2011
Collaborative cancer epidemiology in the 21st century: the model of cancer consortia. Cancer Epidemiol Biomarkers Prev (2013) 0.92
Gynecologic cancer screening and communication with health care providers in women with Lynch syndrome. Clin Genet (2013) 0.82
Decisions about prophylactic gynecologic surgery: a qualitative study of the experience of female Lynch syndrome mutation carriers. Hered Cancer Clin Pract (2015) 0.82
Reflex testing for Lynch syndrome: if we build it, will they come? Lessons learned from the uptake of clinical genetics services by individuals with newly diagnosed colorectal cancer (CRC). Fam Cancer (2014) 0.82
Perceived economic burden associated with an inherited cardiac condition: a qualitative inquiry with families affected by arrhythmogenic right ventricular cardiomyopathy. Genet Med (2015) 0.77
Sense of coherence and self-concept in Lynch syndrome. Hered Cancer Clin Pract (2013) 0.76
Quality indicators to assess a colorectal cancer prevention program. Int J Technol Assess Health Care (2013) 0.75
Evaluation of a Population Based Approach to Familial Colorectal Cancer. Clin Genet (2016) 0.75
Development and preliminary testing of the psychosocial adjustment to hereditary diseases scale. BMC Psychol (2013) 0.75
How does genetic risk information for Lynch syndrome translate to risk management behaviours? Hered Cancer Clin Pract (2017) 0.75
A comparison between Lynch syndrome and sporadic colorectal cancer survivors' satisfaction with their healthcare providers. Cancer Med (2017) 0.75
Hereditary colorectal cancer. N Engl J Med (2003) 11.86
Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology (2000) 8.41
Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA (2006) 4.87
A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genet Med (2008) 3.06
Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research. Soc Sci Med (2005) 2.78
Genetic risk and behavioural change. BMJ (2001) 2.64
Critical issues in the identification and management of patients with hereditary non-polyposis colorectal cancer. Eur J Gastroenterol Hepatol (2005) 2.16
Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology. Am J Gastroenterol (2002) 1.86
Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Am J Gastroenterol (2002) 1.86
The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med (2003) 1.84
Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. Fam Cancer (2007) 1.82
Impact of genetic counseling and testing on colorectal cancer screening behavior. Genet Test (2002) 1.81
Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology (2005) 1.76
The impact of predictive genetic testing for hereditary nonpolyposis colorectal cancer: three years after testing. Genet Med (2007) 1.74
Surveillance colonoscopy in individuals at risk for hereditary nonpolyposis colorectal cancer: an evidence-based review. Dis Colon Rectum (2006) 1.63
Clinical relevance of microsatellite instability in colorectal cancer. J Clin Oncol (2010) 1.62
Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet (2006) 1.59
Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures. Fam Cancer (2005) 1.58
Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol (2004) 1.54
Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Arch Intern Med (2004) 1.48
Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC). Fam Cancer (2007) 1.45
Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma. Cancer (2005) 1.42
Screening behavior of individuals at high risk for colorectal cancer. Gastroenterology (2005) 1.39
Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. Fam Cancer (2006) 1.30
The effect of experiential knowledge on construction of risk perception in hereditary breast/ovarian cancer. J Genet Couns (2005) 1.26
Illness representations, self-regulation, and genetic counseling: a theoretical review. J Genet Couns (2006) 1.22
Predictive testing for hereditary nonpolyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress, and health-related behavior at one year post-test. Genet Test (2005) 1.19
Colorectal cancer screening: practices and opinions of primary care physicians. Prev Med (2004) 1.17
Screening participation in individuals with a family history of colorectal cancer: a review. Eur J Cancer Care (Engl) (2008) 1.17
What process attributes of clinical genetics services could maximise patient benefits? Eur J Hum Genet (2008) 1.11
Perceptions of cancer risks and predictors of colon and endometrial cancer screening in women undergoing genetic testing for Lynch syndrome. J Clin Oncol (2008) 1.11
Family communication, genetic testing and colonoscopy screening in hereditary non-polyposis colon cancer: a qualitative study. Psychooncology (2009) 1.10
Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress. Patient Educ Couns (2006) 1.10
Personal theories of inheritance, coping strategies, risk perception and engagement in hereditary non-polyposis colon cancer families offered genetic testing. Clin Genet (2003) 1.10
Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model. CMAJ (2009) 1.03
The phenotypic expression of three MSH2 mutations in large Newfoundland families with Lynch syndrome. Fam Cancer (2007) 1.01
Review article: The Lynch syndrome (hereditary nonpolyposis colorectal cancer). Aliment Pharmacol Ther (2007) 1.00
Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis. Fam Cancer (2007) 0.95
The emotional effects of genetic diseases: implications for clinical genetics. Am J Med Genet A (2007) 0.93
Psychosocial issues in cancer genetics--current status and future directions. Acta Oncol (2003) 0.92
Anticipated reactions to genetic testing for hereditary non-polyposis colorectal cancer susceptibility. Clin Genet (2004) 0.88
Patients' and professionals' opinions of services for people at an increased risk of colorectal cancer: an exploratory qualitative study. Fam Cancer (2004) 0.87
Predictive genetic testing and beyond: a theory of engagement. J Health Psychol (2002) 0.86
Family and personal history in colorectal cancer patients: what are we missing? Colorectal Dis (2006) 0.83
Hereditary nonpolyposis colorectal cancer (Lynch syndrome): molecular pathogenesis and clinical approaches to diagnosis and management for nurses. Biol Res Nurs (2008) 0.82
The management of families affected by hereditary non-polyposis colorectal cancer (HNPCC). Fam Cancer (2007) 0.82
Psychological impact of predictive testing for colonic cancer. J Health Psychol (2000) 0.76
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med (2012) 8.88
Comparative genomics identifies a flagellar and basal body proteome that includes the BBS5 human disease gene. Cell (2004) 6.10
Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med (2006) 4.37
Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet (2008) 2.84
Mutations in a member of the Ras superfamily of small GTP-binding proteins causes Bardet-Biedl syndrome. Nat Genet (2004) 2.64
Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet (2011) 2.35
MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer. J Natl Cancer Inst (2007) 2.24
Clinical and genetic epidemiology of Bardet-Biedl syndrome in Newfoundland: a 22-year prospective, population-based, cohort study. Am J Med Genet A (2005) 2.03
Cancer risks for relatives of patients with serrated polyposis. Am J Gastroenterol (2012) 1.88
Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience. Circulation (2011) 1.87
The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). J Am Coll Cardiol (2005) 1.83
A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trial. Clin J Am Soc Nephrol (2011) 1.58
Genetic education for primary care providers: improving attitudes, knowledge, and confidence. Can Fam Physician (2009) 1.40
Prediction of Lynch syndrome in consecutive patients with colorectal cancer. J Natl Cancer Inst (2009) 1.40
Effects of guided imagery on blood pressure in pregnant women with hypertension: a pilot randomized controlled trial. Birth (2010) 1.39
Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm. Am J Kidney Dis (2012) 1.38
Relatives of colorectal cancer patients: factors associated with screening behavior. Am J Prev Med (2003) 1.28
Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease. Am Heart J (2005) 1.25
Cost-effectiveness analysis of a randomized trial comparing care models for chronic kidney disease. Clin J Am Soc Nephrol (2011) 1.21
Sudden cardiac death in chronic kidney disease: epidemiology and prevention. Nat Rev Nephrol (2011) 1.17
Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease. Clin J Am Soc Nephrol (2010) 1.17
Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years. Clin J Am Soc Nephrol (2006) 1.15
High frequency of hereditary colorectal cancer in Newfoundland likely involves novel susceptibility genes. Clin Cancer Res (2005) 1.11
Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. Int J Cancer (2011) 1.10
A randomized controlled trial of mindfulness-based stress reduction to manage affective symptoms and improve quality of life in gay men living with HIV. J Behav Med (2011) 1.09
Evaluating genetic counseling for family members of individuals with schizophrenia in the molecular age. Schizophr Bull (2012) 1.08
Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients. Carcinogenesis (2011) 1.07
An investigation of the disclosure process and support needs of BRCA1 and BRCA2 carriers. Am J Med Genet A (2004) 1.02
Reasons given by relatives of colorectal cancer patients for not undergoing screening. Prev Med (2004) 1.02
Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial. Nephrol Dial Transplant (2012) 1.01
The phenotypic expression of three MSH2 mutations in large Newfoundland families with Lynch syndrome. Fam Cancer (2007) 1.01
Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trial. Clin J Am Soc Nephrol (2009) 1.01
The educational needs and professional roles of Canadian physicians and nurses regarding genetic testing and adult onset hereditary disease. Community Genet (2005) 1.01
Newfoundland rod-cone dystrophy, an early-onset retinal dystrophy, is caused by splice-junction mutations in RLBP1. Am J Hum Genet (2002) 1.00
Validity of random-digit-dialing in recruiting controls in a case-control study. Am J Health Behav (2009) 1.00
Impact of gender and parent of origin on the phenotypic expression of hereditary nonpolyposis colorectal cancer in a large Newfoundland kindred with a common MSH2 mutation. Dis Colon Rectum (2002) 0.99
Congestive heart failure in chronic kidney disease: disease-specific mechanisms of systolic and diastolic heart failure and management. Cardiol Clin (2005) 0.98
Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s). Kidney Int (2012) 0.97
Evaluating genetic counseling for individuals with schizophrenia in the molecular age. Schizophr Bull (2012) 0.96
Should healthcare providers have a duty to warn family members of individuals with an HNPCC-causing mutation? A survey of patients from the Ontario Familial Colon Cancer Registry. J Med Genet (2007) 0.96
Dietary patterns and colorectal cancer recurrence and survival: a cohort study. BMJ Open (2013) 0.95
Specific variants in the MLH1 gene region may drive DNA methylation, loss of protein expression, and MSI-H colorectal cancer. PLoS One (2010) 0.95
Profound, prelingual nonsyndromic deafness maps to chromosome 10q21 and is caused by a novel missense mutation in the Usher syndrome type IF gene PCDH15. Eur J Hum Genet (2008) 0.95
Adult siblings with homozygous G6PC3 mutations expand our understanding of the severe congenital neutropenia type 4 (SCN4) phenotype. BMC Med Genet (2012) 0.94
A couple-based intervention for patients and caregivers facing end-stage cancer: outcomes of a randomized controlled trial. Psychooncology (2011) 0.94
Pickled meat consumption and colorectal cancer (CRC): a case-control study in Newfoundland and Labrador, Canada. Cancer Causes Control (2010) 0.93
Colorectal cancer linkage on chromosomes 4q21, 8q13, 12q24, and 15q22. PLoS One (2012) 0.93
Increased cancer predisposition in family members of colorectal cancer patients harboring the p.V600E BRAF mutation: a population-based study. Cancer Epidemiol Biomarkers Prev (2010) 0.93
The phases of disclosing BRCA1/2 genetic information to offspring. Psychooncology (2008) 0.93
Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy. Psychooncology (2004) 0.93
MSH2 118T>C and MSH6 159C>T promoter polymorphisms and the risk of colorectal cancer. Carcinogenesis (2007) 0.92
Mechanisms of the cardiorenal syndromes. Nat Rev Nephrol (2009) 0.91
Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial. Clin J Am Soc Nephrol (2011) 0.90
100 years Lynch syndrome: what have we learned about psychosocial issues? Fam Cancer (2013) 0.89
Clinical and genetic epidemiology of inherited renal disease in Newfoundland. Kidney Int (2002) 0.89
Tobacco smoking and colorectal cancer: a population-based case-control study in Newfoundland and Labrador. Can J Public Health (2010) 0.89
Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapy. Clin J Am Soc Nephrol (2008) 0.89
Calcium and vitamin D and risk of colorectal cancer: results from a large population-based case-control study in Newfoundland and Labrador and Ontario. Can J Public Health (2011) 0.88
A Newfoundland cohort of familial and sporadic idiopathic pulmonary fibrosis patients: clinical and genetic features. Respir Res (2012) 0.88
Familial risk of preeclampsia in Newfoundland: a population-based study. J Am Soc Nephrol (2002) 0.88
Vitamin D intake is negatively associated with promoter methylation of the Wnt antagonist gene DKK1 in a large group of colorectal cancer patients. Nutr Cancer (2012) 0.87
A couples intervention for patients facing advanced cancer and their spouse caregivers: outcomes of a pilot study. Psychooncology (2008) 0.86
The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation. Psychooncology (2011) 0.84
Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning. Fam Cancer (2010) 0.84
Predictors of quality of life in women with a bilateral prophylactic mastectomy. Breast J (2005) 0.84
Inherited deleterious variants in GALNT12 are associated with CRC susceptibility. Hum Mutat (2012) 0.84
International perspectives on genetic counseling and testing for breast cancer risk. Breast Dis (2007) 0.83
How haematological cancer nurses experience the threat of patients' mortality. J Adv Nurs (2011) 0.83
Predictors of registered nurses' organizational commitment and intent to stay. Health Care Manage Rev (2007) 0.83
Interaction between alcohol drinking and obesity in relation to colorectal cancer risk: a case-control study in Newfoundland and Labrador, Canada. BMC Public Health (2012) 0.82
Reported intake of selected micronutrients and risk of colorectal cancer: results from a large population-based case-control study in Newfoundland, Labrador and Ontario, Canada. Anticancer Res (2012) 0.82
Psychological impact of recall on women with BRCA mutations undergoing MRI surveillance. Breast (2011) 0.82
Autosomal recessive Bardet-Biedl syndrome: first-degree relatives have no predisposition to metabolic and renal disorders. Kidney Int (2009) 0.81
Quality of life in CKD patients treated with erythropoiesis-stimulating agents. Am J Kidney Dis (2010) 0.81
The clinical epidemiology of cardiovascular disease in chronic kidney disease. Curr Opin Nephrol Hypertens (2005) 0.81
BNP in hemodialysis patients. Clin J Am Soc Nephrol (2010) 0.81
Communication of genetic test results to family and health-care providers following disclosure of research results. Genet Med (2013) 0.81
Moderators of cancer-related distress and worry after a pancreatic cancer genetic counseling and screening intervention. Psychooncology (2011) 0.80
Inhibitors of the renin angiotensin system: proven benefits, unproven safety. Ann Intern Med (2007) 0.79
Multiple risk factor intervention in chronic kidney disease: management of cardiac disease in chronic kidney disease patients. Med Clin North Am (2005) 0.79
Limited impact on self-concept in individuals with Lynch syndrome; results from a national cohort study. Fam Cancer (2011) 0.79
Target hemoglobin level for EPO therapy in CKD. Am J Kidney Dis (2006) 0.79
Attitudes toward genetic testing in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol (2007) 0.79
Can self-esteem, mastery and perceived stigma predict long-term adjustment in women carrying a BRCA1/2-mutation? Evidence from a multi-center study. Fam Cancer (2010) 0.78
The design of randomized controlled trials. Methods Mol Biol (2009) 0.78
Validation of a self-concept scale for Lynch syndrome in different nationalities. J Genet Couns (2011) 0.78
Dietary patterns and colorectal cancer: results from a Canadian population-based study. Nutr J (2015) 0.78
Qualitative research in clinical epidemiology. Methods Mol Biol (2009) 0.78
Erythropoietin-stimulating agents in chronic kidney disease: a response to hyporesponsiveness. Semin Dial (2011) 0.77
The breast cancer hormone receptor retesting controversy in Newfoundland and Labrador, Canada: lessons for the health system. Healthc Manage Forum (2010) 0.77